99% Savings - Buy Just @1 Rs X
Triolmesar CH 20 Tablet is a prescription drug, available for use as Tablet. The alternative uses of Triolmesar CH 20 Tablet have also been explained below.
The right dosage of Triolmesar CH 20 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Triolmesar CH 20 Tablet also has some side effects, the most common being Upper respiratory tract infection, Loss of appetite, Gastric Irritation. Besides the aforementioned side effects, there are other adverse effects of Triolmesar CH 20 Tablet as well, which are listed below. These side effects of Triolmesar CH 20 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Triolmesar CH 20 Tablet is Mild for pregnant women and Mild for women who are breastfeeding. Warnings related to Triolmesar CH 20 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Triolmesar CH 20 Tablet is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) as it can result in adverse effects. Some other conditions that can be affected by Triolmesar CH 20 Tablet are listed in the contraindications section below.
Additionally, Triolmesar CH 20 Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Triolmesar CH 20 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Triolmesar CH 20 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Triolmesar CH 20 Tablet safe for pregnant women?
Triolmesar CH has little to no side effects in pregnant women.
Is the use of Triolmesar CH 20 Tablet safe during breastfeeding?
Breastfeeding women can take Triolmesar CH as it bears very minor side effects for them.
What is the effect of Triolmesar CH 20 Tablet on the Kidneys?
Triolmesar CH has very mild side effects on the kidneys.
What is the effect of Triolmesar CH 20 Tablet on the Liver?
Side effects of Triolmesar CH rarely affect the liver.
What is the effect of Triolmesar CH 20 Tablet on the Heart?
Triolmesar CH may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Triolmesar CH 20 Tablet unless your doctor advises you to do so -
Is this Triolmesar CH 20 Tablet habit forming or addictive?
No, there is no any evidence that Triolmesar CH 20 Tablet is addictive.
Interaction between Food and Triolmesar CH 20 Tablet
Some foods when eaten with Triolmesar CH 20 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Triolmesar CH 20 Tablet
Taking alcohol with Triolmesar CH 20 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448